Sanofi Forms Joint Venture to Develop Respiratory Syncytial Virus Vaccine
French pharmaceutical group Sanofi agreed to co-develop and manufacture a respiratory syncytial virus vaccine with a United States biotechnology company as competition grows in preventive respiratory treatments.